Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C. - Wikidata - wikimedia - TriplyDB

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C.

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q38076757

about

Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.In vitro assessment of the biologic activity of interferon beta formulations used for the treatment of relapsing multiple sclerosis.Treatment of Delta Hepatitis: Today and in the Future - A review.IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation

P2860

Q37099708-5970A782-FB9A-4203-991F-A8676F4FF450 Q38181142-729BF331-586B-4C0C-A34B-E56E83FD3F74 Q38657226-94C13940-12FC-493F-A772-FF466CE5E150 Q38769975-9CD80818-76F2-4AC0-8FE5-31BB9E52BDEC Q40564211-460A592B-25F5-4C42-82A5-75C02922BFA1 Q42236150-560AD128-8AFC-4E4A-8D6C-198B42119F62 Q42238119-F0BD5FB1-AE6C-4570-8A5E-194AFBAC65CF Q47564469-25C834FF-3787-4D37-B868-FC8331A0A522 Q58787768-3BFED73A-355E-44BA-93FF-7E9054E9CEC6

P2860

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q38076757

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiviral activity of the inte ...... atment of chronic hepatitis C.

@en

type

label

Antiviral activity of the inte ...... atment of chronic hepatitis C.

@en

prefLabel

Antiviral activity of the inte ...... atment of chronic hepatitis C.

@en

P1433

Q38076757-061C211F-5380-4CC1-8BF2-CDF759C9894F

P1476

Q38076757-C3A4AAFF-8606-4B98-A4D8-2C28A2A96360

P2093

Q38076757-578D6C24-EC21-493C-AC7A-B875D2CC9C94

Q38076757-643B824A-9193-471D-8085-C86AC5DA8858

P2860

Q38076757-007429C0-7A1A-4AEE-9F4F-A8EEAFDA04D8

Q38076757-01687255-FCFF-4D79-AD90-996ACA55200B

Q38076757-01EE675E-0B52-4FF1-974F-CA9FAB9B6EF8

Q38076757-06CD2C10-6EA1-4F59-94C1-732D62593E0E

Q38076757-086007C6-EEF6-4473-99EC-9AF03E74AA61

Q38076757-0D739FF3-900A-41D2-88C7-AC13AD022651

Q38076757-0D7AA025-F70D-481E-8DCC-89508E03F49A

Q38076757-0F861F0E-6BFD-4829-BC4A-BAD21C273A50

Q38076757-1862693E-3C2F-4DE8-9B80-8C99AC77D3EF

Q38076757-192AFAF7-B5F3-4E08-AC07-C26DC31DDCBC

P304

Q38076757-2EC46055-9031-4321-AF46-851501233134

P31

Q38076757-A7A1BF33-C872-4E75-BBF1-67A8438B7BCA

P356

Q38076757-BF1E219A-75B7-4E3A-9FA0-D9E7B593BA72

P407

Q38076757-7BF87B01-C44C-4815-84B0-9C39B0855A89

P433

Q38076757-DCE05EDD-6796-43A3-A658-1ABA94E5481A

P478

Q38076757-19977789-4219-4EFF-BAAC-674D7FB80365

P577

Q38076757-2CC10BAD-3409-4AAB-A5F6-9BCAC8CAB48C

P698

Q38076757-EFEB07A2-CA83-4C38-8BA8-F075511344FA

P356

14712598.2013.764409

P1433

Expert Opinion on Biological Therapy

P1476

Antiviral activity of the inte ...... atment of chronic hepatitis C.

@en

P2093

Carolina Scagnolari

http://www.w3.org/2001/XMLSchema#string

Guido Antonelli

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses

Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines

IL-28, IL-29 and their class II cytokine receptor IL-28R

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Viperin: a multifunctional, interferon-inducible protein that regulates virus replication

INTERFEROME: the database of interferon regulated genes

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

P304

693-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2013.764409

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23350850

http://www.w3.org/2001/XMLSchema#string